A single photobiomodulation session reduced bacterial load in acute burn [...]

SolasCure has reported positive phase 2 data for Aurase Wound [...]

Almirall delivered net sales growth of 12.4% in 2025, surpassing [...]

Almirall has received regulatory approval in China for its oral [...]

A new preclinical study using a porcine skin model has [...]

Almirall has announced plans to initiate a phase 3 clinical [...]

Hyphens Pharma International Limited (Hyphens Pharma), a Singapore-based specialty pharmaceutical [...]

Almirall has hosted the fourth edition of ImmunoSkin, its annual [...]

Protagonist Therapeutics has reported new clinical and preclinical data at [...]

Johnson & Johnson has reported new data from the Phase [...]